… and without the EBMT Nurses Group's support, I wouldn’t have been able to attend the Annual Meeting. I think I … recognition.  I am currently advancing my training in CAR-T therapy, and it was highly educational listen to … on this subject and patient management undergoing CAR-T therapy in other countries. From my perspective, …

… allogeneic and autologous stem cells transplantations and CAR-T cells therapies. Laura attended the JACIE Inspector …

… study is: ‘ Uncovering the mode of action of engineered T cells in patient cancer organoids ’ The link to the full … we applied to understand and improve the mode of action of T cell immunotherapy against cancer. This research led to the … you decide to do this study? A: T-cell therapies, such as CAR-T cells, are a promising type of immunotherapy that are …

… immunotherapies with a focus on patients treated with CAR-T cells which included references to the EBMT registry. …

… for the abstract LARGE-SCALE TCR DEEP SEQUENCING REVEALS A T CELL DIVERSITY BOTTLENECK WITH POST-TRANSPLANT … Del Bufalo (Italy) for the presentation titled: CAR-T cells for relapsed or refractory neuroblastoma – a hype … Kingdom) for the presentation titled: Base edited CD7 CAR-T cell therapy in relapsed T-ALL BEST YOUNG ABSTRACTS 11 …

… been reported. The combination with other drugs isn’t routinely recommended and should be limited to certain … HHV6 encephalitis has also been reported following CAR-T-cell therapy. JCV can cause progressive multifocal … outcome in patients, who had undergone Auto/AlloSCT and CAR-T cell therapy, were presented. ECIL-2021 recommendations …

… aspergillosis in the patient with angioimmunoblastic T cell lymphoma after haploHSCT and discussed persistence of … to the computer work. Session 5: Infections after CAR-T therapy Summary by Lidia Gil, Physician, Department of … of Medical Sciences, Poznan, Poland Infections after CAR T cell therapy was one of the most interesting session. …

… with an exciting , state-of- the- art update on novel CAR-T cell therapy for calreticulin ( CALR )-mutated MF. This …

… Infections following CAR-T therapy. A retrospective collaborative study between the …

… for me this year are around the development of the CAR T-cell therapies but also the special sessions about COVID-19 … specialty that have most excited you in recent years? Is CAR-T one of the highlights? A: Of course CAR T-cell …